Product Information
OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 20-5-12.5 is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.7762 per EA under NDC 33342024307. Its NADAC has been published 36 times since Jan 28, 2026.
FDA first approved this application on Jul 18, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 20-5-12.5
Olmesartan medoxomil Amlodipine and HydrochlorothiazideStrength
5; 12.5; 20 mg/1; mg/1; mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342024307
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMILApproval Type
Generic (ANDA)
FDA Application
ANDA207088FDA Approved
7/18/2025
TE Code
AB
On Market Since
7/18/2025
Pharmacological Classes
Price Statistics
The NADAC for OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 20-5-12.5 has been published 36 times since Jan 28, 2026, and over the history we have for it it has declined 15.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7762 per EA |
|---|---|
| All-time high | $0.9312 (Mar 11, 2026) |
| All-time low | $0.7432 (Aug 19, 2026) |
| 52-week high | $0.9312 |
| 52-week low | $0.7432 |
| Median price | $0.8664 |
| Average price | $0.8470 |
| Largest weekly change | -10.7% (Jul 22, 2026) |
| Weeks tracked | 36 |
| Tracking since | Jan 28, 2026 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Macleods Pharmaceuticals Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Olmesartan medoxomil Amlodipine and Hydrochlorothiazide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Angiotensin 2 Receptor Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 20-5-12.5?
The current National Average Drug Acquisition Cost (NADAC) for OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 20-5-12.5, manufactured by Macleods Pharmaceuticals Limited, is $0.7762 per EA (NDC 33342024307), effective Sep 30, 2026.
How has the price of OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 20-5-12.5 changed over time?
Over the history we have for it, the NADAC for OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 20-5-12.5 has declined 15.7%. It has been tracked across 36 weekly CMS publications since Jan 28, 2026.
What are the highest and lowest recorded NADAC prices for OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 20-5-12.5?
Since Jan 28, 2026, the NADAC for OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 20-5-12.5 has ranged from a low of $0.7432 (Aug 19, 2026) to a high of $0.9312 (Mar 11, 2026), with a median of $0.8664 per EA.
Are there cheaper alternatives to OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 20-5-12.5?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 20-5-12.5 in a comparable dosage form, but none are currently priced below it.
Who manufactures OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 20-5-12.5?
OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 20-5-12.5 (NDC 33342024307) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.